Paper39744211
Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction.
Qin D and 3 others. Front Cardiovasc Med, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction. Papers, record 39744211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39744211
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References260
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36140386 | Recent Advances in Extracellular Vesicle-Based Therapies Using Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140386 | PubMed |
| 2 | 27336721 | Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27336721 | PubMed |
| 3 | 31981320 | Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo. | ESC Heart Fail | 2020 | https://conductscience.org/library/papers/31981320 | PubMed |
| 4 | 33391474 | Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. | Theranostics | 2021 | https://conductscience.org/library/papers/33391474 | PubMed |
| 5 | 29921652 | Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b. | Circ Res | 2018 | https://conductscience.org/library/papers/29921652 | PubMed |
| 6 | 33785738 | Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. | Nat Commun | 2021 | https://conductscience.org/library/papers/33785738 | PubMed |
| 7 | 33824273 | The effect of extracellular vesicles on the regulation of mitochondria under hypoxia. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33824273 | PubMed |
| 8 | 31007875 | Metabolic signature of extracellular vesicles depends on the cell culture conditions. | J Extracell Vesicles | 2019 | https://conductscience.org/library/papers/31007875 | PubMed |
| 9 | 17476341 | APC-derived cytokines and T cell polarization in autoimmune inflammation. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17476341 | PubMed |
| 10 | 31505198 | Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. | J Mol Cell Cardiol | 2019 | https://conductscience.org/library/papers/31505198 | PubMed |
| 11 | 24725987 | Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. | Cell Commun Signal | 2014 | https://conductscience.org/library/papers/24725987 | PubMed |
| 12 | 31276786 | Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization. | Int J Biochem Cell Biol | 2019 | https://conductscience.org/library/papers/31276786 | PubMed |
| 13 | 33742276 | miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury. | Basic Res Cardiol | 2021 | https://conductscience.org/library/papers/33742276 | PubMed |
| 14 | 38969034 | An injectable exosome-loaded hyaluronic acid-polylysine hydrogel for cardiac repair via modulating oxidative stress and the inflammatory microenvironment. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38969034 | PubMed |
| 15 | 26754424 | MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. | Cell Commun Signal | 2016 | https://conductscience.org/library/papers/26754424 | PubMed |
| 16 | 35716062 | Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. | J Extracell Vesicles | 2022 | https://conductscience.org/library/papers/35716062 | PubMed |
| 17 | 31103607 | Current research trends and challenges in tissue engineering for mending broken hearts. | Life Sci | 2019 | https://conductscience.org/library/papers/31103607 | PubMed |
| 18 | 28249798 | Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28249798 | PubMed |
| 19 | 31533317 | Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31533317 | PubMed |
| 20 | 35813192 | Biological Features of Extracellular Vesicles and Challenges. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35813192 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794856 | Lipid Cargo of Small Extracellular Vesicles as a Novel Contributor to Cardiovascular Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794856 | PubMed |
| 42792732 | Small Extracellular Vesicles in Cardioprotection, Cardiac Repair, and Regeneration: Cargo Mechanisms, Producer Cell Sources, and Translational Development. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792732 | PubMed |
| 42711596 | Extracellular vesicles for next-gen therapeutics and drug delivery. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42711596 | PubMed |
| 42455291 | Electrical Stimulation-Induced Modulation of Small Extracellular Vesicles in Regenerative Therapy. | Tissue Eng Regen Med | 2026 | https://conductscience.org/library/papers/42455291 | PubMed |
| 42194330 | Artificial Intelligence-Enabled Bioengineering of Extracellular Vesicle Platforms in Cardiovascular Medicine. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42194330 | PubMed |
| 42193908 | Extracellular Vesicles in Cardiac Repair Approaches: Implications for In Vitro Heart Models and Potential ATMP Development. | Cells | 2026 | https://conductscience.org/library/papers/42193908 | PubMed |
| 42041584 | Extracellular Vesicles Derived from VEGF mRNA-Engineered Mesenchymal Stem Cells Promote Endothelial Cell Survival. | Cells | 2026 | https://conductscience.org/library/papers/42041584 | PubMed |
| 42016346 | Nanomedicine for Cardiac Repair in Heart Failure: From Targeted Delivery to Regenerative Modulation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42016346 | PubMed |
| 41823811 | Mesenchymal Stem Cell-Derived Extracellular Vesicles in Myocardial Ischemia-Reperfusion Injury: A Comprehensive Review. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41823811 | PubMed |
| 41808887 | Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions. | World J Stem Cells | 2026 | https://conductscience.org/library/papers/41808887 | PubMed |
| 41727547 | Mesenchymal stem cell-derived exosomes in myocardial infarction repair: therapeutic potential and scaffold-based delivery strategies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41727547 | PubMed |
| 41620394 | Exercise intensity-dependent cardiac telocyte expansion is associated with physiological growth despite JAK/STAT pathway inactivity in male Wistar rats. | Exp Physiol | 2026 | https://conductscience.org/library/papers/41620394 | PubMed |
| 41537152 | Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation. | Regen Ther | 2026 | https://conductscience.org/library/papers/41537152 | PubMed |
| 41516086 | Mesenchymal Stem Cell Secretome for Cardiac Regeneration: Opportunity for Cell-Free Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516086 | PubMed |
| 41341098 | Comparative analysis of dental-derived stem cells and alternative stem cell sources: properties and regenerative functions. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41341098 | PubMed |
| 40236257 | Elucidating the preventive and therapeutic effects of cardiac telocytes paracrine microRNAs on ischemic heart disease. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40236257 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39744211
GET https://conductscience.org/api/papers/v1/39744211/references?page=2